SCHEMBL8529159

SCHEMBL8529159

CC(O)C(NC(=O)C(N)CCC(=O)O)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.59
DPP8 Q6V1X1 2/20 0.59
DPP9 Q86TI2 2/20 0.59
CYP1A2 P05177 2/20 0.50
GRM8 O00222 1/20 0.50
GRM6 O15303 1/20 0.50
GRIN2D O15399 1/20 0.50
GRIN3B O60391 1/20 0.50
GSR P00390 1/20 0.50
GRIK1 P39086 1/20 0.50
GRM5 P41594 1/20 0.50
GRIA1 P42261 1/20 0.50
GRIA2 P42262 1/20 0.50
GRIA3 P42263 1/20 0.50
SLC1A3 P43003 1/20 0.50
SLC1A2 P43004 1/20 0.50
SLC1A1 P43005 1/20 0.50
GRIA4 P48058 1/20 0.50
GRIN1 Q05586 1/20 0.50
GRIN2A Q12879 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4388333 1.00 DPP4 (0.59) DPP4DPP8DPP9CYP1A2GRM8
SCHEMBL30924861 0.93 DPP4 (0.52) DPP4DPP8DPP9CYP1A2GRM8
SCHEMBL30361178 0.93 DPP4 (0.52) DPP4DPP8DPP9CYP1A2GRM8
SCHEMBL30562167 0.91 DPP4 (0.51) DPP4DPP8DPP9PDCD1LG2CD274
SCHEMBL31688167 0.90 DPP4 (0.50) DPP4DPP8DPP9CYP1A2GRM8
SCHEMBL29539434 0.90 DPP4 (0.50) DPP4DPP8DPP9CYP1A2GRM8
SCHEMBL29816159 0.89 BACE1 (0.53) DPP4DPP8DPP9CTSDBACE1
SCHEMBL30997362 0.89 BACE1 (0.53) DPP4DPP8DPP9CTSDBACE1
SCHEMBL5970526 0.89 DPP4 (0.58) DPP4DPP8DPP9CYP1A2GRM8
SCHEMBL4388337 0.89 DPP4 (0.58) DPP4DPP8DPP9CYP1A2GRM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311927-A Sugar-dipeptides conjugates as flavor molecules 雀巢产品技术援助有限公司 2019-02-05 CN claimed
WO-2016112174-A2 Biomarkers of Sleep Deprivation and Cognitive Impairment THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2016-07-14 WO claimed
WO-2013188333-A1 BIOMARKERS RELATED TO NEPHROTOXICITY AND METHODS USING THE SAME METABOLON, INC. (US) 2013-12-19 WO claimed
US-12259397-B2 Biomarkers related to organ function University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2025-03-25 US disclosed
US-20250025520-A1 MICROBE-BASED MODULATION OF SEROTONIN BIOSYNTHESIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-01-23 US disclosed
CN-119296764-A Marker for detecting sensitivity of tumor radiotherapy and screening method and application thereof 福建医科大学附属协和医院 2025-01-10 CN disclosed
CN-119165078-A Combined marker for detecting tumor radiotherapy sensitivity and application thereof 福建医科大学附属协和医院 2024-12-20 CN disclosed
US-12050228-B2 Automated sample quality assessment METABOLON, INC. (US) 2024-07-30 US disclosed
WO-2024010854-A1 RAPID GENERATION OF BREATH-BASED HEALTH REPORTS AND SYSTEMS FOR USE IN THE SAME DIAGNOSE EARLY, INC. (US) 2024-01-11 WO disclosed
EP-3987064-A1 METHOD FOR DIAGNOSING ESTHETIC DEGRADATIONS OF SKIN L'OREAL (FR) 2022-04-27 EP disclosed
CN-114269951-A Diagnostic method for aesthetic deterioration of skin 欧莱雅 2022-04-01 CN disclosed
US-8980548-B2 Methods and reagents for metabolomics and histology in a biological sample and a kit for the same METABOLON, INC. (US) 2015-03-17 US disclosed
US-20140296134-A1 METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-10-02 US disclosed
US-20140271930-A1 NONINVASIVE METHOD FOR MEASURING METABOLITES FOR SKIN HEALTH THE PROCTER & GAMBLE COMPANY (US) 2014-09-18 US disclosed
EP-2776829-A1 METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION The Board of Regents of The University of Texas System (US) 2014-09-17 EP disclosed
US-8658351-B2 Determining liver toxicity of an agent using metabolite biomarkers METABOLON, INC. (US) 2014-02-25 US disclosed
WO-2013155528-A2 METHODS FOR REDUCING BRAIN INFLAMMATION, INCREASING INSULIN SENSITIVITY, AND REDUCING CERAMIDE LEVELS FASGEN, INC. (US) 2013-10-17 WO disclosed
WO-2013070962-A1 METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-05-16 WO disclosed
US-20130115649-A1 Methods and Reagents for Metabolomics and Histology in a Biological Sample and a Kit for the Same METABOLON, INC. 2013-05-09 US disclosed
EP-0885899-A1 Method for obtaining peptide fragments by use of fluorinated organic acids SEIKO INSTRUMENTS INC. (JP) 1998-12-23 EP disclosed